Filing Flows › biote (BTMD) › Q3 2026 › vs Q2 2026
biote (BTMD) Q3 2026 vs Q2 2026 (quarter over quarter)
biote's revenue fell $898K (-2%) from $44.2M in Q2 2026 to $43.3M in Q3 2026. Operating margin 5.7% against -7.9% (+13.7 pts).
biote, Q3 2026: revenue $43.3M (-10% year over year), operating margin 5.7%, net earnings $407K, operating cash flow $3.7M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 5.7% | -7.9% | +13.7 pts |
| Net margin | 0.9% | -14.8% | +15.8 pts |
| Free cash flow margin | 2.6% | -8.4% | +11.0 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $43.3M | $44.2M | −$898K | -2% |
| Operating profit | $2.5M | −$3.5M | $6.0M | — |
| Costs & expenses | $40.8M | $47.7M | −$6.9M | -14% |
| Pre-tax earnings | $1.4M | −$7.1M | $8.5M | — |
| Other expense, net | $1.1M | $3.6M | −$2.5M | -69% |
| Cost of revenue | $14.0M | $15.3M | −$1.3M | -9% |
| SG&A | $26.8M | $32.4M | −$5.6M | -17% |
| Net earnings | $407K | −$6.6M | $7.0M | — |
| Minority interests | $162K | −$865K | $1.0M | — |
| Income tax | $796K | $296K | $500K | +169% |
| Depreciation & amortization | $1.0M | $963K | $65K | +7% |
| Share-based compensation | $1.3M | $2.0M | −$628K | -32% |
| Working capital & other | $909K | $2.5M | −$1.5M | -63% |
| Operating cash flow | $3.7M | −$1.2M | $4.9M | — |
| Free cash flow (OCF − capex) | $1.1M | −$3.7M | $4.8M | — |
| Capital expenditures | $2.6M | $2.6M | $20K | +0.8% |
Questions
How much did biote's revenue grow quarter over quarter in Q3 2026?
biote's revenue fell $898K (-2%) from $44.2M in Q2 2026 to $43.3M in Q3 2026. Operating margin 5.7% against -7.9% (+13.7 pts).